India's Cadila healthcare company will purchase Claris lifesciences sterile injection imitation process for us $534 million
-
Last Update: 2015-05-25
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Biovalley 2015-05-25 May 25, 2015, according to the report of Indian Economic Weekly on Thursday, Cadila health care company plans to purchase Claris lifesciences sterile injection production process for 34 billion rupees (534 million US dollars), and the negotiation has entered the final stage According to the news, the two sides are exchanging views closely, and the results are expected to be announced next month Earlier this year, Claris denied that it was discussing the acquisition of the injection industry and said it had not even considered it But amneal pharmaceuticals, Novartis and Pfizer all showed interest in Claris, according to Indian Economic Weekly If Cadila fails to acquire, the possibility for lupin to acquire Claris will increase, according to wired In 2014, the Claris injection industry generated a total of 4 billion rupees (US $62.8 million) of revenue throughout the year, half of which came from emerging markets In Brazil and Russia, for example, a total of 1.5 billion rupees (US $23.6 million) of profits were generated A spokesman for Cadila said the company would not comment on market expectations for policy reasons At the same time, a spokesman for Claris was not in favor of such an act Claris shares are reported to have risen 11%.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.